Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Lung Cancer|Liver Cancer|Colorectal Cancer|Pancreas Cancer|Ovary Cancer|Head and Neck Cancer|Breast Cancer|Gastric Cancer|Cervical Cancer|Esophageal Cancer|Sarcoma
Interventions: DRUG: ipilimumab +pembrolizumab +durvalumab
Sponsor: Second Affiliated Hospital of Guangzhou Medical University